Plozasiran Reduces Triglyceride Levels by 74% at 24 Weeks :

Novel drug shows promise for treating severe hypertriglyceridemia in patients at high risk for pancreatitis

Related Keywords

Montreal , Quebec , Canada , Daniel Gaudent , Daniel Gaudet , University Of Montreal , American College Of Cardiology Annual Scientific Session , Arrowhead Pharmaceuticals , American College , Annual Scientific ,